Clinical diagnosis of Leber congenital amaurosis (LCA)/early-onset retinal degeneration (EORD) and of severely impaired visual and retinal function, and best corrected visual acuity of 20/40 or worse in the study eye;
Ability to perform tests of visual and retinal function;
Visible photoreceptor layer on a standard OCT scan;
Good general health;
Ability to comply with research procedures;
Specific for Cohorts 1, 2 and 4: 18 years of age and older;
Specific for Cohorts 3 and 5: Between 8 and 17 years of age, inclusive.
You may not be if
AAV antibody titers greater than two standard deviations above normal at baseline;
Humoral immune deficiency as evidenced by low tetanus toxoid IgG antibody titers;
Pre-existing eye conditions that would preclude the planned surgery or interfere with the interpretation of study endpoints or surgical complications;
Complicating systemic diseases;
Use of anti-platelet agents that may alter coagulation within 7 days prior to study agent administration;
Use of immunosuppressive medications;
Pregnancy or breastfeeding;
Individuals (males and females) of childbearing potential who are unwilling to use effective contraception;
Any condition that would prevent a subject from completing follow-up examinations during the course of the study;
Any condition that makes the subject unsuitable for the study;
Current, or recent participation, in any other research protocol involving investigational agents or therapies;
Recent receipt of an investigational biologic therapeutic agent.